Prospective Grant of Exclusive License: Promotion of Homologous Recombination DNA Pairing by RecA And RecA Peptides

Özet

This notice is accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(I) that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of an exclusive world-wide license to practice the inventions embodied in U.S. Patents No. 5,460,941, entitled, ``Method of Targeting DNA'' and 5,510,473, entitled, ``Cloning of the RecA Gene From Thermus Aquaticus YT-1'', U.S. Patent Applications Serial Numbers 08/446,413, entitled, ``Cloning of the RecA Gene From Thermus Aquaticus YT-1'', 08/483,115 entitled, ``Promotion of Homologous Recombination DNA Pairing By Rec-A- Derived Peptides'', 60/001,384 and 08/682,305, ``Rec A Assisted Cloning of DNA'', and corresponding U.S. and foreign patent applications to the Pangene Corporation of Menlo Park, California. The patent rights in these inventions have been assigned to the United States of America.